The 3rd Vulnerable Plaque Satellite Symposium

                March 16, 2002 , Centennial Park Inforum Auditorium,  Atlanta, Georgia

[Scientific Sessions] [Industry Panel]

  Scientific Sessions 

[Speakers] [Posters and Slide Presentations]

HTML Presentations

1:00 PM: Opening Remarks, Introducing the AEHA Guideline on the Definition of Vulnerable Plaque

Morteza Naghavi, MD Assistant Professor, University of Texas-Houston and Texas Heart Institute
(Power Point)

1:10 PM: Inflammation Links Atherosclerosis to Thrombosis; Where Can We Break the Chain?

Peter Libby, MD Malinckrodt Professor of Medicine, Harvard Medical School

 

1:20 PM: The Latest on Vulnerable Plaque Pathology Ð Different Types of Vulnerable Plaque

Renu Virmani, MD Professor, Cardiovascular Pathology, Armed Forces Institute of Pathology, USA

 

1:30 PM: Michael Davies AEHA Featured Lecture: Culprit Plaque Lessons Learned From 9,000 Autopsies

Erling Falk, MD, PhD Professor of Pathology, Aarhus University Hospital, Denmark
(Power Point)

 

1:40 PM: Genes Expressed in Culprit Plaques - Do We Know Enough?

Larry Adams MD Department of Pathology, University of Washington

1:50 PM: Valentin Fuster AEHA Featured Lecture The Vulnerable Patient: Vulnerable Plaque + Vulnerable Blood = Vulnerable Patient

Juan Jose Badimon, PhD Professor of Pathology, Cardiovascular Institute, Mount Sinai Medical Center

 

2:00 PM  Intravascular Elastography: Palpating Plaques with the Finger of IVUS

Chris de Korte, PhD Professor of Pathology, Aarhus University Hospital, Denmark
(Power Point)

 

2:10 PM  Can Coated Stents be the Therapy of Choice for VP and is it Cost-Effective?

Roxana Mehran, MD Professor of Pathology, Aarhus University Hospital, Denmark

2:20 PM  MRI Noninvasive Plaque Characterization: The Future is Here?

Chun Yuan PhD, Professor of Radiology, University of Washington
(Power Point)

 

2:30 PM  Apo-A1 Milano Therapy: One-Month Cleaning Service of Coronary Arteries!?

PK Shah, MD, Professor of Medicine, Cedars -Sinai Medical Center and UCLA school of Medicine

 

2:40 PM  CRP, CD40L, or the New PAPP-A: Which Best Identifies Vulnerable Patients?

Robert S.chwartz, MD, Professor of Medicine, Mayo Clinic

 

2:50 PM:  Emerging Animal Models of Vulnerable Plaque: Are We Close to an Optimal Model?

Chris Jackson PhD, Bristol Heart Institute, University of Bristol
(Power Point)

 

  Poster/Slide Presentation  (1:00 pm - 6:00pm) 

AEHA Council on Pathology of Vulnerable Plaque:

- 3D Animation Movie on Different Types of Vulnerable Plaques (Movie)
Morteza Naghavi, MD

- Criteria for the Definition of Constrictive and Expansive Remodeling in Pathological and Clinical Settings
G. Pasterkamp MD, PhD (Power Point)

- Revisiting the Basics, Culprit vs. Non-Culprit: Luminal Narrowing, Plaque Volume &Cap Thickness
Silvio Litovsky, MD (Power Point)
 

AEHA Council on Biology of Vulnerable Plaque

- Atherosclerosis, an Autoimmune Disease? Mohammad Madjid, MD (Power Point)

- Macrophage-Induced Proteolysis: How Many MMPs and Non-MMPs Are Involved?

Zorina Galis, PhD (Power Point)

-Macrophage-Induced Proteolysis: How Many MMPs and Non-MMPs Are Involved?
Masanori Aikawa, MD, PhD  (Power Point)

- Macrophage Apoptosis: a Double Edge Sword?
Silvio Litovsky, MD (Power Point)

- From C. Pneumonia to Influenza A: Atherosclerosis: An Infectious Disease? Or Complicated by Infectious Disease?
Mohamad Navab, PhD (Power Point)

- Effect of Testosterone on Neo-Intimal Plaque Development and Arterial Androgen Receptor Expression in Male Versus Female Rabbits
Hartmut Hanke, MD (Power Point)
Wolfgang Weidemann, PhD

- The Prevalence of Inflammatory Cells in Non-Ruptured Atherosclerotic Plaques
G.Pasterkamp, MD, PhD (Power Point)

- Arterial Remodeling In Stable Versus Unstable Coronary Syndromes: An Intravascular Ultrasound Study
Paul Schoenhagen, MD (Power Point)

- Metabolic Dyslipidemia in Insulin Resistant States
Khosrow Adeli, PhD (Power Point: Part 1 - 2 - 3 - 4)

 AEHA Council on Detection of Vulnerable Plaque

- Plaque Thermography: Some Like It Hot!
Christodoulos Stefanadis, MD (Power Point: 1-2-3-4-5-6-7-8)

- OCT: Optical Biopsy With Short Photonic Needle!
Ik-Kyung Jang, MD (Power Point)

- OCT for the Identification of Vulnerable Plaque
Mark Brezinski, MD, PhD

- Near Infrared Spectroscopy: Near to or Far From our Expectations? (1)

Pedro Moreno, MD  (Power Point)

- Near Infrared Spectroscopy: Near to or Far From our Expectations? (2)
Robert Lodder, PhD (Power Point)
 

- Multi-slice Fast CT and Electron Beam Tomography: The First Screening Step in Imaging Coronary Atherosclerosis?
Stephan Achenbach, MD (Power Point)

- Intravascular Characterization of Atherosclerotic Lesions with (18)F-FDG and An Novel Intravascular Beta Probe
 Ahmed Tawakol, MD (Power point)

- EBT Calcium Score: A Clue to Invulnerable Plaques In Vulnerable Patients
John Rumberger, MD, PhD (Power Points: 1 2 3 4)

- Coronary Atherosclerosis with Multi-Slice CT: What is Beyond Coronary Calcifications?
Christoph R.  Becker, MD (Power Point)

- Coronary Endothelial Shear Stress Profiling In-Vivo to Predict Progression of Atherosclerosis and In-Stent Restenosis in Man.
Peter Stone, MD (Power Point)

- Noninvasive MR Imaging of Plaque Inflammation: SPIO or Gadolinium?
Maziar Azadpour, MD (Power Point)

- MR Imaging of Fibrin to Detect Plaque Mural Thrombi
Gregory Lanza, MD (Power point)

- MR Imaging for the Evaluation of Carotid Atherosclerosis
David Saloner, PhD (Power Point)

- Intravascular MRI - Diagnostic and Therapeutic Potentials
Ergin Atalar, PhD (Power Point)

- Criteria for Models of Carotid Atherosclerotic Lesions: Quality Control of Clinical MRI Trials
William Insull, Jr., MD (Power Point)
Joel D. Morrisett, PhD

- Cost-effectiveness of a Combined Thermography and IVUS Catheter?
Paul Cherukuri

AEHA Council on Epidemiology of Vulnerable Patients and Triggers of Acute Coronary Syndrome

- Out of Hospital Sudden Cardiac Death (SCD): Declining or Escalating?
Alireza Zarrabi, MD (Power Point)

-Genomic and Proteomic Screening of ACS and Vulnerable Patients
Mehran Haidari, PhD (Power Point)

 

 AEHA Council on treatment of Vulnerable Plaque

- Embolic Protection Devices
Jay Yadav, MD (Power Point)

 

AEHA Council on Animal Model of Vulnerable Plaque and Heart Attack

- Transgenic CETP Dahl Salt-sensitive (Tg53) Rat Model: Is it promising enough?
Victoria L M Herrera, MD (Power Point)

 

BACK - HOME - NEXT